TY - JOUR
T1 - The role of annealing and fragmentation in human tau aggregation dynamics
AU - Huseby, Carol J.
AU - Bundschuh, Ralf
AU - Kuret, Jeff
N1 - Publisher Copyright:
© 2019 Huseby et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2019/3/29
Y1 - 2019/3/29
N2 - Alzheimer’s disease pathogenesis is associated with the conversion of monomeric tau protein into filamentous aggregates. Because both toxicity and prion-like spread of pathogenic tau depend in part on aggregate size, the processes that underlie filament formation and size distribution are of special importance. Here, using a combination of biophysical and computational approaches, we investigated the fibrillation dynamics of the human tau isoform 2N4R. We found that tau filaments engage in a previously uncharacterized secondary process involving end-to-end annealing and that rationalization of empirical aggregation data composed of total protomer concentrations and fibril length distributions requires inclusion of this process along with filament fragmentation. We noted that annealing of 2N4R tau filaments is robust, with an intrinsic association rate constant of a magnitude similar to that mediating monomer addition and consistent with diffusion-mediated protein–protein interactions in the absence of long-range attractive forces. In contrast, secondary nucleation on the surface of tau filaments did not detectably contribute to tau aggregation dynamics. These results indicate that tau filament ends engage in a range of homotypic interactions involving monomers, oligomers, and filaments. They further indicate that, in the case of tau protein, fibril annealing and fragmentation along with primary nucleation and elongation are the major processes controlling filament size distribution.
AB - Alzheimer’s disease pathogenesis is associated with the conversion of monomeric tau protein into filamentous aggregates. Because both toxicity and prion-like spread of pathogenic tau depend in part on aggregate size, the processes that underlie filament formation and size distribution are of special importance. Here, using a combination of biophysical and computational approaches, we investigated the fibrillation dynamics of the human tau isoform 2N4R. We found that tau filaments engage in a previously uncharacterized secondary process involving end-to-end annealing and that rationalization of empirical aggregation data composed of total protomer concentrations and fibril length distributions requires inclusion of this process along with filament fragmentation. We noted that annealing of 2N4R tau filaments is robust, with an intrinsic association rate constant of a magnitude similar to that mediating monomer addition and consistent with diffusion-mediated protein–protein interactions in the absence of long-range attractive forces. In contrast, secondary nucleation on the surface of tau filaments did not detectably contribute to tau aggregation dynamics. These results indicate that tau filament ends engage in a range of homotypic interactions involving monomers, oligomers, and filaments. They further indicate that, in the case of tau protein, fibril annealing and fragmentation along with primary nucleation and elongation are the major processes controlling filament size distribution.
UR - http://www.scopus.com/inward/record.url?scp=85063952119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063952119&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA118.006943
DO - 10.1074/jbc.RA118.006943
M3 - Article
C2 - 30745358
AN - SCOPUS:85063952119
SN - 0021-9258
VL - 294
SP - 4728
EP - 4737
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 13
ER -